258 related articles for article (PubMed ID: 26867770)
21. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
Sivaprasad U; Shankar E; Basu A
Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
[TBL] [Abstract][Full Text] [Related]
22. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
[TBL] [Abstract][Full Text] [Related]
23. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
[TBL] [Abstract][Full Text] [Related]
24. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
25. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
Ozören N; El-Deiry WS
Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
[TBL] [Abstract][Full Text] [Related]
26. Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway.
Chen Z; Sangwan V; Banerjee S; Chugh R; Dudeja V; Vickers SM; Saluja AK
Cancer Lett; 2014 Jun; 348(1-2):156-66. PubMed ID: 24662747
[TBL] [Abstract][Full Text] [Related]
27. Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells.
Garnett TO; Filippova M; Duerksen-Hughes PJ
Apoptosis; 2007 Jul; 12(7):1299-315. PubMed ID: 17431792
[TBL] [Abstract][Full Text] [Related]
28. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3.
Choi WY; Jin CY; Han MH; Kim GY; Kim ND; Lee WH; Kim SK; Choi YH
Anticancer Res; 2009 Nov; 29(11):4457-65. PubMed ID: 20032392
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
[TBL] [Abstract][Full Text] [Related]
30. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
31. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis.
Huang YY; Liu H; Li Y; Pu LJ; Jiang CC; Xu JC; Jiang ZW
Eur J Pharmacol; 2013 Apr; 705(1-3):26-34. PubMed ID: 23499682
[TBL] [Abstract][Full Text] [Related]
33. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine.
Wong SHM; Fang CM; Loh HS; Ngai SC
Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402
[TBL] [Abstract][Full Text] [Related]
34. eNOS protects prostate cancer cells from TRAIL-induced apoptosis.
Tong X; Li H
Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122
[TBL] [Abstract][Full Text] [Related]
35. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Kazhdan I; Marciniak RA
Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
[TBL] [Abstract][Full Text] [Related]
36. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
[TBL] [Abstract][Full Text] [Related]
37. Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.
Lincoln FA; Imig D; Boccellato C; Juric V; Noonan J; Kontermann RE; Allgöwer F; Murphy BM; Rehm M
Cell Death Dis; 2018 Nov; 9(11):1112. PubMed ID: 30385739
[TBL] [Abstract][Full Text] [Related]
38. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA
Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581
[TBL] [Abstract][Full Text] [Related]
39. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
40. The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria.
Ortiz-Ferrón G; Tait SW; Robledo G; de Vries E; Borst J; López-Rivas A
Cell Death Differ; 2006 Nov; 13(11):1857-65. PubMed ID: 16485030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
